Switch theme
Sign up to access all valuation multiples
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
2015
2.4K+
LTM Revenue $830M
LTM EBITDA $25.2M
$402M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
InnovAge has a last 12-month revenue of $830M and a last 12-month EBITDA of $25.2M.
In the most recent fiscal year, InnovAge achieved revenue of $764M and an EBITDA of $1.2M.
InnovAge expects next 12-month revenue of XXX and NTM EBITDA of XXX
See InnovAge valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $688M | $764M | XXX | XXX | XXX |
| Gross Profit | $135M | $101M | XXX | XXX | XXX |
| Gross Margin | 20% | 13% | XXX | XXX | XXX |
| EBITDA | -$33.9M | $1.2M | XXX | XXX | XXX |
| EBITDA Margin | -5% | 0% | XXX | XXX | XXX |
| Net Profit | -$6.5M | -$40.7M | XXX | XXX | XXX |
| Net Margin | -1% | -5% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, InnovAge's stock price is $3.
InnovAge has current market cap of $383M, and EV of $402M.
See InnovAge trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $402M | $383M | XXX | XXX | XXX | XXX | $-0.12 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, InnovAge has market cap of $383M and EV of $402M.
InnovAge's trades at 0.5x LTM EV/Revenue multiple, and 16.0x LTM EBITDA.
Analysts estimate InnovAge's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for InnovAge and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $402M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 28.1x | XXX | XXX | XXX |
| P/E | -18.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -38.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpInnovAge's NTM/LTM revenue growth is 10%
InnovAge's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, InnovAge's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate InnovAge's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for InnovAge and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -103% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 12% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 20% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
InnovAge acquired XXX companies to date.
Last acquisition by InnovAge was XXXXXXXX, XXXXX XXXXX XXXXXX . InnovAge acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was InnovAge founded? | InnovAge was founded in 2015. |
| Where is InnovAge headquartered? | InnovAge is headquartered in United States of America. |
| How many employees does InnovAge have? | As of today, InnovAge has 2.4K+ employees. |
| Who is the CEO of InnovAge? | InnovAge's CEO is Mr. Patrick Blair. |
| Is InnovAge publicy listed? | Yes, InnovAge is a public company listed on NAS. |
| What is the stock symbol of InnovAge? | InnovAge trades under INNV ticker. |
| When did InnovAge go public? | InnovAge went public in 2021. |
| Who are competitors of InnovAge? | Similar companies to InnovAge include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of InnovAge? | InnovAge's current market cap is $383M |
| What is the current revenue of InnovAge? | InnovAge's last 12-month revenue is $830M. |
| What is the current EBITDA of InnovAge? | InnovAge's last 12-month EBITDA is $25.2M. |
| What is the current EV/Revenue multiple of InnovAge? | Current revenue multiple of InnovAge is 0.5x. |
| What is the current EV/EBITDA multiple of InnovAge? | Current EBITDA multiple of InnovAge is 16.0x. |
| What is the current revenue growth of InnovAge? | InnovAge revenue growth between 2023 and 2024 was 11%. |
| Is InnovAge profitable? | Yes, InnovAge is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
